What is ADMA Biologics's deferred income?

ADMA Biologics (ADMA) reported deferred income of $1.37M in Q1 2026.

How has ADMA Biologics's deferred income changed year-over-year?

ADMA Biologics's deferred income decreased by 9.5% year-over-year, from $1.51M to $1.37M.

What is the long-term trend for ADMA Biologics's deferred income?

Over 5 years (2020 to 2025), ADMA Biologics's deferred income has grown at a -7.9% compound annual growth rate (CAGR), from $2.12M to $1.41M.

ADMA Biologics ADMA Deferred income

Deferred income at other companies

TG TherapeuticsTGTX

——

Aurinia PharmaceuticalsAUPH

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's deferred income?: ADMA Biologics (ADMA) reported deferred income of $1.37M in Q1 2026.
How has ADMA Biologics's deferred income changed year-over-year?: ADMA Biologics's deferred income decreased by 9.5% year-over-year, from $1.51M to $1.37M.
What is the long-term trend for ADMA Biologics's deferred income?: Over 5 years (2020 to 2025), ADMA Biologics's deferred income has grown at a -7.9% compound annual growth rate (CAGR), from $2.12M to $1.41M.